New study links prenatal chemical exposure to childhood obesity trajectories

The FDA ap­proved Am­gen’s mon­o­clon­al an­ti­body Bkemv as the first in­ter­change­able biosim­i­lar for Alex­ion’s block­buster Soliris to treat two types of rare blood dis­eases, the

Sev­en years af­ter Stealth Bio­Ther­a­peu­tics land­ed a fast track des­ig­na­tion from the FDA, the agency has fi­nal­ly agreed to re­view the com­pa­ny’s ap­pli­ca­tion for an